Related Experiment Video

Updated: Nov 29, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.6K

Short-Term Outcomes After Multisystem Inflammatory Syndrome in Children Treatment

Katharine N Clouser1, Jasmine Gadhavi1, Sejal M Bhavsar1

  • 1Department of Pediatrics, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center and Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA.

Journal of the Pediatric Infectious Diseases Society
|November 19, 2020
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) patients showed favorable outcomes. A consensus-driven algorithm led to a return to baseline function within 30 days for most children studied.

Area of Science:

  • Pediatric rheumatology
  • Pediatric infectious diseases
  • Pediatric critical care medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition requiring prompt management.
  • Treatment protocols for MIS-C have evolved, with a need to evaluate current approaches.
  • Understanding patient responses to standardized treatment is crucial for improving care.

Purpose of the Study:

  • To evaluate the effectiveness of a consensus-driven treatment algorithm for MIS-C.
  • To describe the clinical spectrum and treatment course of MIS-C patients.
  • To assess the rate of return to functional baseline following treatment.

Main Methods:

  • Retrospective chart review of 20 pediatric patients diagnosed with MIS-C.
  • Analysis of patient treatments based on a predefined, consensus-driven algorithm.
  • Assessment of clinical status and functional recovery at 30 days post-presentation.

Main Results:

  • The study included 20 MIS-C patients with diverse clinical presentations.
  • All patients received treatment guided by a consensus-driven algorithm.
  • A favorable return to functional baseline was observed in the majority of patients within 30 days.

Conclusions:

  • A consensus-driven treatment algorithm appears effective for managing MIS-C.
  • Prompt treatment adherence is associated with positive clinical outcomes in MIS-C.
  • Further research should focus on long-term outcomes and refining MIS-C treatment strategies.

Keywords:
COVID-19hospital careintensive care

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.1K
Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.3K

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
311
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
306
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
88
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
338
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
281
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
111